The Importance of Subgroup Analysis in Drug-Eluting Stent Trials

Saved in:
Bibliographic Details
Published in:JACC. Cardiovascular interventions 2016-01, Vol.9 (1), p.39-41
Main Author: Abbott, J. Dawn, MD
Format: Article
Language:English
Subjects:
Cardiovascular
chronic kidney disease
Coronary Artery Disease - drug therapy
Coronary Restenosis - drug therapy
drug-eluting stent(s)
Drug-Eluting Stents
Humans
Myocardial Infarction - drug therapy
Paclitaxel
Sirolimus - therapeutic use
Stents
Time Factors
Treatment Outcome
women
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1936-8798
1876-7605
1876-7605
DOI:10.1016/j.jcin.2015.11.006